Texas 2009 - 81st Regular

Texas Senate Bill SB1886 Compare Versions

The same version is selected twice. Please select two different versions to compare.
OldNewDifferences
11 By: Ellis S.B. No. 1886
22
33
44 A BILL TO BE ENTITLED
55 AN ACT
66 relating to diagnostic testing of pregnant women and certain
77 newborns.
88 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
99 SECTION 1. The heading to Section 81.090, Health and Safety
1010 Code, is amended to read as follows:
1111 Sec. 81.090. DIAGNOSTIC [SEROLOGIC] TESTING DURING
1212 PREGNANCY AND AFTER BIRTH.
1313 SECTION 2. Section 81.090, Health and Safety Code, is
1414 amended by amending Subsections (a), (b), (c), (i), (j), (k), and
1515 (l) and adding Subsections (a-1), (c-1), and (c-2) to read as
1616 follows:
1717 (a) A physician or other person permitted by law to attend a
1818 pregnant woman during gestation or at delivery of an infant shall:
1919 (1) take or cause to be taken a sample of the woman's
2020 blood or other appropriate specimen at the first examination and
2121 visit;
2222 (2) submit the sample to an appropriately certified
2323 [a] laboratory [approved under this section] for diagnostic testing
2424 approved by the United States Food and Drug Administration for:
2525 (A) [a standard serologic test for] syphilis
2626 [approved by the board];
2727 (B) [a standard serologic test for] HIV infection
2828 [approved by the board]; and
2929 (C) [a standard serologic test for] hepatitis B
3030 infection [approved by the board]; and
3131 (3) retain a report of each case for nine months and
3232 deliver the report to any successor in the case.
3333 (a-1) A physician or other person permitted by law to attend
3434 a pregnant woman during gestation or at delivery of an infant shall:
3535 (1) take or cause to be taken a sample of the woman's
3636 blood or other appropriate specimen at an examination in the third
3737 trimester of the pregnancy;
3838 (2) submit the sample to an appropriately certified
3939 laboratory for a diagnostic test approved by the United States Food
4040 and Drug Administration for HIV infection; and
4141 (3) retain a report of each case for nine months and
4242 deliver the report to any successor in the case.
4343 (b) A successor is presumed to have complied with this
4444 section if the successor in good faith obtains a record that
4545 indicates compliance with Subsections (a) and (a-1), if applicable.
4646 (c) A physician or other person in attendance at a delivery
4747 shall:
4848 (1) take or cause to be taken a sample of blood or
4949 other appropriate specimen from the mother on admission for
5050 delivery; and
5151 (2) submit the sample to an appropriately certified
5252 [a] laboratory [approved under this section] for diagnostic testing
5353 approved by the United States Food and Drug Administration for:
5454 (A) [a standard serologic test for] syphilis
5555 [approved by the board]; and
5656 (B) [a standard serologic test for HIV infection
5757 approved by the board; and
5858 [(C) a standard serologic test for] hepatitis B
5959 infection [approved by the board].
6060 (c-1) If the physician or other person in attendance at the
6161 delivery does not find in the woman's medical records results from
6262 the diagnostic test for HIV infection performed under Subsection
6363 (a-1), the physician or person shall:
6464 (1) take or cause to be taken a sample of blood or
6565 other appropriate specimen from the mother;
6666 (2) submit the sample to an appropriately certified
6767 laboratory for diagnostic testing approved by the United States
6868 Food and Drug Administration for HIV infection; and
6969 (3) instruct the laboratory to expedite the processing
7070 of the test so that the results are received less than six hours
7171 after the time the sample is submitted.
7272 (c-2) If the physician or other person in attendance at the
7373 delivery does not find in the woman's medical records results from a
7474 diagnostic test for HIV infection performed under Subsection (a-1),
7575 and the diagnostic test for HIV infection was not performed before
7676 delivery under Subsection (c-1), the physician or other person in
7777 attendance at delivery shall:
7878 (1) take or cause to be taken a sample of blood or
7979 other appropriate specimen from the newborn child less than two
8080 hours after the time of birth;
8181 (2) submit the sample to an appropriately certified
8282 laboratory for a diagnostic test approved by the United States Food
8383 and Drug Administration for HIV infection; and
8484 (3) instruct the laboratory to expedite the processing
8585 of the test so that the results are received less than six hours
8686 after the time the sample is submitted.
8787 (i) Before conducting or causing to be conducted a
8888 diagnostic [standard serologic] test for HIV infection under this
8989 section, the physician or other person shall advise the woman that
9090 the result of a test taken under this section is confidential as
9191 provided by Subchapter F, but that the test is not anonymous. The
9292 physician or other person shall explain the difference between a
9393 confidential and an anonymous test to the woman and that an
9494 anonymous test may be available from another entity. The physician
9595 or other person shall make the information available in another
9696 language, if needed, and if resources permit. The information
9797 shall be provided by the physician or another person, as needed, in
9898 a manner and in terms understandable to a person who may be
9999 illiterate if resources permit.
100100 (j) The result of a [standard] test for HIV infection under
101101 Subsection (a)(2)(B), (a-1), (c-1), or (c-2) [(c)(2)(B)] is a test
102102 result for purposes of Subchapter F.
103103 (k) Before the [blood] sample is taken, the health care
104104 provider shall distribute to the patient printed materials about
105105 AIDS, HIV, hepatitis B, and syphilis. A health care provider shall
106106 verbally notify the patient that an HIV test shall be performed if
107107 the patient does not object. If the patient objects, the patient
108108 shall be referred to an anonymous testing facility or instructed
109109 about anonymous testing methods. The health care provider shall
110110 note on the medical records that the distribution of printed
111111 materials was made and that verbal notification was given. The
112112 materials shall be provided to the health care provider by the
113113 department [Texas Department of Health] and shall be prepared and
114114 designed to inform the patients about:
115115 (1) the incidence and mode of transmission of AIDS,
116116 HIV, hepatitis B, and syphilis;
117117 (2) how being infected with HIV, AIDS, hepatitis B, or
118118 syphilis could affect the health of their child;
119119 (3) the available cure for syphilis;
120120 (4) the available treatment to prevent
121121 maternal-infant HIV transmission; and
122122 (5) methods to prevent the transmission of the HIV
123123 virus, hepatitis B, and syphilis.
124124 (l) A physician or other person may not conduct a diagnostic
125125 [standard] test for HIV infection under Subsection (a)(2)(B),
126126 (a-1), or (c-1) [(c)(2)(B)] if the woman objects. A physician or
127127 other person may not conduct a diagnostic test for HIV infection
128128 under Subsection (c-2) if a parent, managing conservator, or
129129 guardian objects.
130130 SECTION 3. Subsections (d), (e), (f), and (h), Section
131131 81.090, Health and Safety Code, are repealed.
132132 SECTION 4. (a) Subsections (a), (c), (i), and (k), Section
133133 81.090, Health and Safety Code, as amended by this Act, apply only
134134 to a test performed on or after the effective date of this Act. A
135135 test performed before the effective date of this Act is covered by
136136 the law in effect immediately before the effective date of this Act,
137137 and the former law is continued in effect for that purpose.
138138 (b) Subsections (a-1), (c-1), and (c-2), Section 81.090,
139139 Health and Safety Code, as added by this Act, and Subsections (b),
140140 (j), and (l), Section 81.090, Health and Safety Code, as amended by
141141 this Act, apply only to a physician or other person attending a
142142 pregnant woman during gestation or at delivery of an infant on or
143143 after January 1, 2010.
144144 SECTION 5. This Act takes effect September 1, 2009.